315 related articles for article (PubMed ID: 32109664)
1. Hsa-miR-140-5p down-regulates LDL receptor and attenuates LDL-C uptake in human hepatocytes.
Xu Y; Gao J; Gong Y; Chen M; Chen J; Zhao W; Tan S
Atherosclerosis; 2020 Mar; 297():111-119. PubMed ID: 32109664
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-148a regulates LDL receptor and ABCA1 expression to control circulating lipoprotein levels.
Goedeke L; Rotllan N; Canfrán-Duque A; Aranda JF; Ramírez CM; Araldi E; Lin CS; Anderson NN; Wagschal A; de Cabo R; Horton JD; Lasunción MA; Näär AM; Suárez Y; Fernández-Hernando C
Nat Med; 2015 Nov; 21(11):1280-9. PubMed ID: 26437365
[TBL] [Abstract][Full Text] [Related]
3. microRNA-185 modulates low density lipoprotein receptor expression as a key posttranscriptional regulator.
Jiang H; Zhang J; Du Y; Jia X; Yang F; Si S; Wang L; Hong B
Atherosclerosis; 2015 Dec; 243(2):523-32. PubMed ID: 26523989
[TBL] [Abstract][Full Text] [Related]
4. microRNA-483 ameliorates hypercholesterolemia by inhibiting PCSK9 production.
Dong J; He M; Li J; Pessentheiner A; Wang C; Zhang J; Sun Y; Wang WT; Zhang Y; Liu J; Wang SC; Huang PH; Gordts PL; Yuan ZY; Tsimikas S; Shyy JY
JCI Insight; 2020 Dec; 5(23):. PubMed ID: 33119548
[TBL] [Abstract][Full Text] [Related]
5. A Common Polymorphism in the
Beehler K; Nikpay M; Lau P; Dang AT; Lagace TA; Soubeyrand S; McPherson R
Arterioscler Thromb Vasc Biol; 2021 Aug; 41(8):2252-2262. PubMed ID: 34134519
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-27a decreases the level and efficiency of the LDL receptor and contributes to the dysregulation of cholesterol homeostasis.
Alvarez ML; Khosroheidari M; Eddy E; Done SC
Atherosclerosis; 2015 Oct; 242(2):595-604. PubMed ID: 26318398
[TBL] [Abstract][Full Text] [Related]
7. MK-2206, an allosteric inhibitor of AKT, stimulates LDLR expression and LDL uptake: A potential hypocholesterolemic agent.
Bjune K; Sundvold H; Leren TP; Naderi S
Atherosclerosis; 2018 Sep; 276():28-38. PubMed ID: 30025252
[TBL] [Abstract][Full Text] [Related]
8. Farnesoid X Receptor Activation by Obeticholic Acid Elevates Liver Low-Density Lipoprotein Receptor Expression by mRNA Stabilization and Reduces Plasma Low-Density Lipoprotein Cholesterol in Mice.
Singh AB; Dong B; Kraemer FB; Xu Y; Zhang Y; Liu J
Arterioscler Thromb Vasc Biol; 2018 Oct; 38(10):2448-2459. PubMed ID: 30354208
[TBL] [Abstract][Full Text] [Related]
9. Piceatannol reduces resistance to statins in hypercholesterolemia by reducing PCSK9 expression through p300 acetyltransferase inhibition.
Kim HJ; Lee J; Chung MY; Hong S; Park JH; Lee SH; Park SW; Choi HK; Hwang JT
Pharmacol Res; 2020 Nov; 161():105205. PubMed ID: 32998069
[TBL] [Abstract][Full Text] [Related]
10. Platycodin D enhances LDLR expression and LDL uptake via down-regulation of IDOL mRNA in hepatic cells.
Choi YJ; Lee SJ; Kim HI; Lee HJ; Kang SJ; Kim TY; Cheon C; Ko SG
Sci Rep; 2020 Nov; 10(1):19834. PubMed ID: 33199761
[TBL] [Abstract][Full Text] [Related]
11. Curcumin enhances cell-surface LDLR level and promotes LDL uptake through downregulation of PCSK9 gene expression in HepG2 cells.
Tai MH; Chen PK; Chen PY; Wu MJ; Ho CT; Yen JH
Mol Nutr Food Res; 2014 Nov; 58(11):2133-45. PubMed ID: 25164566
[TBL] [Abstract][Full Text] [Related]
12. RP1-13D10.2 Is a Novel Modulator of Statin-Induced Changes in Cholesterol.
Mitchel K; Theusch E; Cubitt C; Dosé AC; Stevens K; Naidoo D; Medina MW
Circ Cardiovasc Genet; 2016 Jun; 9(3):223-30. PubMed ID: 27071970
[TBL] [Abstract][Full Text] [Related]
13. Lunasin Improves the LDL-C Lowering Efficacy of Simvastatin via Inhibiting PCSK9 Expression in Hepatocytes and ApoE
Gu L; Gong Y; Zhao C; Wang Y; Tian Q; Lei G; Liang Y; Zhao W; Tan S
Molecules; 2019 Nov; 24(22):. PubMed ID: 31731717
[TBL] [Abstract][Full Text] [Related]
14. miR-27b inhibits LDLR and ABCA1 expression but does not influence plasma and hepatic lipid levels in mice.
Goedeke L; Rotllan N; Ramírez CM; Aranda JF; Canfrán-Duque A; Araldi E; Fernández-Hernando A; Langhi C; de Cabo R; Baldán Á; Suárez Y; Fernández-Hernando C
Atherosclerosis; 2015 Dec; 243(2):499-509. PubMed ID: 26520906
[TBL] [Abstract][Full Text] [Related]
15. The critical role of mRNA destabilizing protein heterogeneous nuclear ribonucleoprotein d in 3' untranslated region-mediated decay of low-density lipoprotein receptor mRNA in liver tissue.
Singh AB; Li H; Kan CF; Dong B; Nicolls MR; Liu J
Arterioscler Thromb Vasc Biol; 2014 Jan; 34(1):8-16. PubMed ID: 24158514
[TBL] [Abstract][Full Text] [Related]
16. Human MicroRNA-548p Decreases Hepatic Apolipoprotein B Secretion and Lipid Synthesis.
Zhou L; Hussain MM
Arterioscler Thromb Vasc Biol; 2017 May; 37(5):786-793. PubMed ID: 28336556
[TBL] [Abstract][Full Text] [Related]
17. Gypenoside LVI improves hepatic LDL uptake by decreasing PCSK9 and upregulating LDLR expression.
Wang J; Wang YS; Huang YP; Jiang CH; Gao M; Zheng X; Yin ZQ; Zhang J
Phytomedicine; 2021 Oct; 91():153688. PubMed ID: 34380071
[TBL] [Abstract][Full Text] [Related]
18. Black Raspberry Extract Enhances LDL Uptake in HepG2 Cells by Suppressing PCSK9 Expression to Upregulate LDLR Expression.
Song KH; Kim YH; Im AR; Kim YH
J Med Food; 2018 Jun; 21(6):560-567. PubMed ID: 29569973
[TBL] [Abstract][Full Text] [Related]
19. Identification of neolignans with PCSK9 downregulatory and LDLR upregulatory activities from Penthorum chinense and the potential in cholesterol uptake by transcriptional regulation of LDLR via SREBP2.
Chae HS; Pel P; Cho J; Kim YM; An CY; Huh J; Choi YH; Kim J; Chin YW
J Ethnopharmacol; 2021 Oct; 278():114265. PubMed ID: 34111537
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-148a regulates low-density lipoprotein metabolism by repressing the (pro)renin receptor.
Wang N; He L; Lin H; Tan L; Sun Y; Zhang X; Danser AHJ; Lu HS; He Y; Lu X
PLoS One; 2020; 15(5):e0225356. PubMed ID: 32437440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
